ZEVRA THERAPEUTICS INCZEVRA THERAPEUTICS INCZEVRA THERAPEUTICS INC

ZEVRA THERAPEUTICS INC

No trades
See on Supercharts

Price target

20.070.000.00%
The 8 analysts offering 1 year price forecasts for 1GDA have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to 1GDA in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


1GDA EPS for the last quarter is −0.62 EUR despite the estimation of −0.37 EUR. In the next quarter EPS is expected to reach −0.38 EUR. Track more of ZEVRA THERAPEUTICS INC financials and stay on top of what is up with the company.
In the next quarter ZEVRA THERAPEUTICS INC revenue is expected to reach ‪8.62 M‬ EUR. Check out ZEVRA THERAPEUTICS INC revenue and earnings and make informed decisions.
According to analysts, 1GDA price target is 20.07 EUR with a max estimate of 24.18 EUR and a min estimate of 14.51 EUR. Check if this forecast comes true in a year, meanwhile watch ZEVRA THERAPEUTICS INC stock price chart and keep track of the current situation with 1GDA news and stock market news.
We've gathered opinions of 8 analysts rating 1GDA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.